IRIS
CAPRANZANO, PIERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.384
AS - Asia 3.097
EU - Europa 2.567
SA - Sud America 462
AF - Africa 374
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 13.894
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.117
SG - Singapore 1.502
CN - Cina 1.156
IE - Irlanda 859
UA - Ucraina 588
IT - Italia 438
BR - Brasile 421
CI - Costa d'Avorio 291
CA - Canada 237
RU - Federazione Russa 196
VN - Vietnam 163
SE - Svezia 125
KR - Corea 99
GB - Regno Unito 70
FR - Francia 65
DE - Germania 61
IN - India 47
SN - Senegal 43
NL - Olanda 24
UZ - Uzbekistan 24
AT - Austria 23
BD - Bangladesh 21
IQ - Iraq 20
BE - Belgio 19
PL - Polonia 19
CH - Svizzera 18
ES - Italia 17
MX - Messico 17
ZA - Sudafrica 17
AR - Argentina 16
FI - Finlandia 15
GR - Grecia 12
HK - Hong Kong 12
TR - Turchia 9
MA - Marocco 8
VE - Venezuela 8
JP - Giappone 7
EC - Ecuador 6
PK - Pakistan 6
EU - Europa 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
NG - Nigeria 4
NP - Nepal 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EG - Egitto 3
OM - Oman 3
AL - Albania 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
HN - Honduras 2
ID - Indonesia 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
TV - Tuvalu 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KI - Kiribati 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.894
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.128
Singapore 865
Dublin 859
Jacksonville 803
Chandler 684
Dallas 615
Houston 497
Boardman 401
Abidjan 291
Nanjing 245
Chicago 237
Hefei 218
Ashburn 217
Andover 214
Cambridge 213
Lawrence 213
Toronto 170
Des Moines 141
Catania 140
Dong Ket 125
Civitanova Marche 105
Seoul 99
Nanchang 83
Wilmington 83
Beijing 76
San Mateo 76
Los Angeles 74
Hebei 63
Shenyang 52
Ottawa 48
Jiaxing 47
Saint Petersburg 45
Dakar 43
Council Bluffs 41
Tianjin 39
Changsha 38
São Paulo 37
The Dalles 37
Columbus 34
Bremen 31
Washington 31
Moscow 24
Seattle 21
Brooklyn 20
Norwalk 20
Pune 20
Brussels 19
New York 18
Rio de Janeiro 18
Kunming 17
Ningbo 17
Falls Church 16
Hangzhou 16
Hanoi 15
Helsinki 14
Jinan 14
Milan 14
Phoenix 14
Belo Horizonte 13
San Francisco 13
Guangzhou 12
Boston 11
Den Haag 11
Hong Kong 11
Amsterdam 10
London 10
Warsaw 10
Johannesburg 9
Stockholm 9
Zhengzhou 9
Baghdad 8
Liberty Lake 8
Mumbai 8
Ann Arbor 7
Atlanta 7
Edinburgh 7
Ho Chi Minh City 7
Palermo 7
Tokyo 7
Charlotte 6
Curitiba 6
Mexico City 6
Munich 6
Porto Alegre 6
Santo André 6
Tashkent 6
Canicattini Bagni 5
Denver 5
Manduria 5
Montevideo 5
Montreal 5
Nuremberg 5
Padova 5
Santos 5
Secaucus 5
Shanghai 5
Taizhou 5
Abuja 4
Anápolis 4
Assago 4
Totale 10.058
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 525
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 160
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 138
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry 121
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 104
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 103
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 99
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 97
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 90
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 89
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 89
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 88
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 87
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 87
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 85
Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry 85
Early cardiovascular remodelling in Fabry disease 85
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey 84
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 83
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 82
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 82
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 82
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 81
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 80
Clinical implication of different plaque distribution patterns in distal left main coronary artery 80
Retrograde Approach for Chronic Total Occlusion Percutaneous Coronary Intervention: The Paradox of Choice 79
Appraisal of key trials in aortic and mitral fields 79
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 79
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 78
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 78
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 77
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 77
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 77
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 77
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 77
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 76
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 76
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 75
Transcatheter Aortic-Valve Replacement 75
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 75
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 74
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 74
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 73
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 73
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 73
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 73
A Novel Mechanism by Which MitraClip Implantation May Favorably Alter the Natural History of Left Ventricular Remodeling in Patients with Mitral Regurgitation: Proposed Role of the Ventricular-Valvular Loop Reply 73
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 72
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 72
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems 71
Update on clinical evidence (Part II): a summary of the main post market studies 71
Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists 71
Transfemoral transcatheter aortic-valve replacement should be preferred over surgery in most intermediate-risk patients. 71
Risk stratification after ST-elevation myocardial infarction 70
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 70
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: Results of the OPTIMUS-2 study 70
Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial 69
Percutaneous Coronary Intervention With Everolimus-Eluting Bioresorbable Vascular Scaffolds In Routine Clinical Practice: Early and Mid-Term Outcomes From The European Multicenter GHOST-EU Registry 69
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy 68
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease 68
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 67
Real world safety and efficacy of the janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting Stent (TEST) registry 67
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 67
Serum cotinine levels are associated with increased clopidogrel-induced antiplatelet effects 67
Capitolo 2 - Diagnostica cardiovascolare 66
L'angioplastica complessa al posto del by-pass: ruolo degli score di rischio 66
Parenteral Anticoagulant Agents in PCI 66
CABG Versus PCI In Diabetic Patients With Multivessel Disease After Risk Stratification By The SYNTAX Score: A Pooled Analysis Of The SYNTAX And FREEDOM Trials 66
Clinical development of selective anticoagulants: a state of the art 65
Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry 65
Self-apposing STENTYS stent in acute myocardial infarction 65
Impact of Residual Platelet Reactivity on reperfusion in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention 65
Percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation in patients with surgical mitral valve repair failure. 64
One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy? 64
Simultaneous plaque rupture and erosion in the same atheroma: insights from two and three-dimensional optical coherence tomography 64
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 64
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 64
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry) 64
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 64
PHARMACODYNAMIC EFFECTS OF DIFFERENT ASPIRIN DOSING REGIMENS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE 64
Early and Midterm Outcomes of Bioresorbable Scaffolds for Ostial Coronary Lesions: Insights from the GHOST-EU Registry 64
Drug-Eluting Stent for Left Main Coronary Artery Disease: The DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment 63
Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients 62
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 62
Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry 61
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonist. A review on its mechanism of action and clinical development 61
Impact of Chronic Kidney Disease on Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Insights From the GRASP Registry 61
Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation 61
Increasing CHADS2 scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleeding 61
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. 60
Long-term outcomes after drug-eluting stent for the treatment of ostial left anterior descending coronary artery lesions 59
Procedural management of patients with advanced heart failure undergoing MitraClip implantation (from the GRASP registry) 59
Impact of Adjunctive Cilostazol Therapy Versus High Maintenance Dose of Clopidogrel in Suboptimal Responders With Diabetes Mellitus 59
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis 58
Antithrombotic Management of Elderly Patients With Coronary Artery Disease 58
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy 58
Revascularization vs. Optimal Medical Therapy in Women with NSTE-ACS 58
Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE registry) 58
Is isolated disease of the ostium left anterior descending or circumflex artery a distal left main pathology? 58
How true delivery profile diminution reduces vascular access challenges and complications 57
Totale 7.868
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.102 0 0 166 5 305 27 166 4 88 2 181 158
2021/20221.478 169 231 2 24 256 15 223 55 116 1 20 366
2022/20232.435 219 51 19 192 333 437 7 380 679 10 75 33
2023/20241.207 63 216 60 87 51 268 31 50 3 29 199 150
2024/20254.141 32 584 281 173 1.041 412 62 147 381 434 250 344
2025/20261.616 512 442 662 0 0 0 0 0 0 0 0 0
Totale 14.284